Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose finasteride and dutasteride reduce PSA levels by 27.8% in men with male androgenetic alopecia.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Opioid use may lower PSA levels, suggesting a possible role in prostate cancer control; PSA testing is useful for detecting prostate cancer; serum triglycerides are not linked to prostate cancer risk; and higher urethral PSA levels may be associated with local hormone activity.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Testosterone replacement therapy improved blood sugar and fat levels without raising prostate cancer risk in Japanese men with low testosterone.

Finasteride treats enlarged prostate and may help with baldness, but effects on sexual function and male fetuses are unclear.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Dutasteride effectively treats benign prostatic hyperplasia but isn't approved for preventing prostate cancer.

Ganoderma lucidum may help treat enlarged prostate in rats.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Lespedeza cuneata extract may help treat enlarged prostate.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Caesalpinia bonduc seed extracts may help treat enlarged prostate in rats.

2007 research improved understanding of prostate cancer risk, diagnosis, and treatment, but also showed the need for personalized treatment and further study on certain therapies' risks.

Finasteride 5 mg effectively reduces urinary symptoms and PSA levels in men with enlarged prostates, with few sexual side effects.

Tripterygium wilfordii multiglycoside effectively reduced prostate enlargement in rats without harmful effects.

Early hair loss may indicate future prostate issues.

Higher urethral PSA levels after prostate removal may be linked to more scalp hair loss and more PSA in urethral glands.

Finasteride treats hair loss but may affect prostate cancer detection.

Finasteride reduces PSA levels, terazosin doesn't affect them, and tracking prostate cancer in patients taking finasteride could be difficult.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

Low testosterone does not prevent prostate cancer in men with type 1 diabetes.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.